Brief: CNS Pharmaceuticals Says Lincoln Park To Purchase Up To $15 Mln Worth Of Co's Common Stock
Sept 21 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* CNS PHARMACEUTICALS INC - LINCOLN PARK HAS COMMITTED TO
PURCHASE
UP TO $15.0 MILLION WORTH OF CO'SS COMMON STOCK
Source text (https://bit.ly/3mBP0Zc)
Further company coverage: CNSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026